glp 1 osteoporosis New Research on GLP-1s & Bone Health 🦴 ​A new large-scale study has raised questions about the long-term effects of GLP-1 receptor agonists (like Ozempic and Wegovy). While these medications are revolutionary Losing weight on GLP-1, but

Companies such as Novo Nordisk and Eli Lilly continue to lead the market with their innovative GLP-1 receptor agonists, contributing to a surge in global sales

The effect is largely consistent throughout the included trials, as indicated by the low heterogeneity

Its mechanism can be summarized as: Activation of the GHRH receptor cAMP/PKA signaling inside pituitary somatotrophs Endogenous growth hormone release Downstream IGF-1 pathway activation DAC-dependent differences in duration and exposure Importantly, CJC-1295 is not growth hormone

Trends in adult body-mass index in 200 countries from 1975 to 2014: A pooled analysis of 1698 population-based measurement studies with 192 million participants (in Eng)

We compared the VCE images of patients who underwent a coffee enema plus PEG flushing to those of patients who received the PEG solution only

Nakamura M, Takahashi T, Matsui H, Baniwa Y, Takahashi S, Murayama SY, Serizawa H, Suzuki H, Hibi T